Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection

Background. Previously we showed that a probiotic combination with L. rhamnosus GG was beneficial as an adjuvant therapy during H. pylori eradication. Aim. To evaluate whether probiotic combination with LGG adheres to the upper gastrointestinal mucosa and modifies H. pylori colonisation and H. pylori induced inflammation. Methods. Thirteen patients referred for gastroduodenoscopy received a drink consisting of equal doses (2.5 x 10(9) CFU) of LGG, L. rhamnosus LC705, Propionibacteriumfreudenreichii JS and Bifidobacterium lactis Bb 12 daily. Recovery of probiotics in biopsies (antrum, corpus, duodenum) and faecal samples was evaluated by strain-specific quantitative polymerase chain reaction. H. pylori colonization and gastric inflammation was investigated by urease activity (C-13-urea breath test), histology and serum pepsinogen 1, 11 and gastrin- 17 measurements. Results. Twelve patients were fully investigated; of these three of the patients had LGG adhering to the biopsies at end of the intervention. Other probiotic strains were not detected, even though the recovery of all individual probiotic strains from the faeces was significantly increased (p < 0.01). After the treatment, the level of C-13-urea breath test (p = 0.063) and gastrin- 17 (p = 0.046) decreased. Conclusions. The decreases in 13C-urea breath test and gastrin-17 indicate that the probiotic combination exerts a beneficial effect on gastric mucosa in H. pylori infected patients. LGG showed marginal ability to adhere to the upper gastrointestinal tract mucosa. (c) 2007 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.